v3.26.1
Share-Based Compensation - Schedule of Transactions Related to the Grant of Options to Employees, Directors and Non-Employees Under the Company’s Options Plan (Details) - USD ($)
6 Months Ended
Jun. 30, 2026
Dec. 31, 2025
Jun. 30, 2026
Schedule of Transactions Related to the Grant of Options to Employees, Directors and Non-Employees Under the Company’s Options Plan [Abstract]      
Number of options, Outstanding balance     7,543,770
Weighted average exercise price, Outstanding balance     $ 0.57
Weighted average remaining contractual term, Outstanding balance 3 years 11 months 1 day 5 years 1 month 6 days  
Aggregate Intrinsic Value, Outstanding balance     $ 23.000
Number of options, Granted     40,000,000
Weighted average exercise price, Granted     $ 0.0000025
Weighted average remaining contractual term, Granted     3 years 9 months
Aggregate Intrinsic Value, Granted     $ 0.1000
Number of options, Expired     (448,000)
Weighted average exercise price, Expired     $ 0.48
Weighted average remaining contractual term, Expired    
Aggregate Intrinsic Value, Expired    
Number of options, Exercisable 13,792,437   13,792,437
Weighted average exercise price, Exercisable $ 0.3   $ 0.3
Weighted average remaining contractual term, Exercisable 4 years 4 months 6 days    
Aggregate Intrinsic Value, Exercisable  
Number of options, Vested and expected to vest at end of period 47,095,770   47,095,770
Weighted average exercise price, Vested and expected to vest at end of period $ 0.09   $ 0.09
Weighted average remaining contractual term, Vested and expected to vest at end of period 3 years 11 months 1 day    
Aggregate Intrinsic Value, Vested and expected to vest at end of period  
Number of options, Outstanding balance 47,095,770 7,543,770 47,095,770
Weighted average exercise price, Outstanding balance $ 0.09 $ 0.57 $ 0.09
Weighted average remaining contractual term, Outstanding balance 3 years 11 months 1 day 5 years 1 month 6 days  
Aggregate Intrinsic Value, Outstanding balance $ 4.000 $ 23.000 $ 4.000